Page last updated: 2024-08-25

rosiglitazone and Atypical Lipomatous Tumor

rosiglitazone has been researched along with Atypical Lipomatous Tumor in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrisani, OM; Bi, P; Bidwell, CA; Castro, B; Durkes, A; Elzey, BD; Freeman, JL; Karki, A; Konieczny, SF; Kuang, S; Wang, C; Wirbisky, SE; Yue, F	1
Benoist, F; Gauthier, A; McPherson, R; Vassiliou, G	1
Debiec-Rychter, M; Debrock, G; Oyen, R; Sciot, R; Van Oosterom, A; Vanhentenrijk, V	1

Trials

1 trial(s) available for rosiglitazone and Atypical Lipomatous Tumor

Article	Year
A phase II trial with rosiglitazone in liposarcoma patients. British journal of cancer, 2003, Oct-20, Volume: 89, Issue:8 Topics: Adult; Disease Progression; DNA-Binding Proteins; Female; Fibrinolytic Agents; Gene Expression Regulation, Neoplastic; Humans; Liposarcoma; Male; Microbodies; Middle Aged; Nuclear Proteins; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Rosiglitazone; Thiazolidinediones; Transcription Factors; Treatment Outcome; Zinc Fingers	2003

Article

Year

A phase II trial with rosiglitazone in liposarcoma patients.

British journal of cancer, 2003, Oct-20, Volume: 89, Issue:8

Topics: Adult; Disease Progression; DNA-Binding Proteins; Female; Fibrinolytic Agents; Gene Expression Regulation, Neoplastic; Humans; Liposarcoma; Male; Microbodies; Middle Aged; Nuclear Proteins; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Rosiglitazone; Thiazolidinediones; Transcription Factors; Treatment Outcome; Zinc Fingers

2003

Other Studies

2 other study(ies) available for rosiglitazone and Atypical Lipomatous Tumor

Article	Year
Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. The Journal of experimental medicine, 2016, 09-19, Volume: 213, Issue:10 Topics: Adipocytes; Animals; Biomarkers, Tumor; Cell Dedifferentiation; Cell Differentiation; Cell Lineage; Cell Proliferation; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Diamines; Dibenzazepines; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ligands; Lipid Metabolism; Liposarcoma; Metabolic Syndrome; Mice, Inbred C57BL; PPAR gamma; Precancerous Conditions; PTEN Phosphohydrolase; Receptors, Notch; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Xenograft Model Antitumor Assays	2016
Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma. The Journal of biological chemistry, 2003, Apr-04, Volume: 278, Issue:14 Topics: Adipocytes; Dimerization; Enhancer Elements, Genetic; Fibrinolytic Agents; Gene Expression; Humans; Ligands; Liposarcoma; Luciferases; Mutagenesis; Promoter Regions, Genetic; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured	2003

Article

Year

Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice.

The Journal of experimental medicine, 2016, 09-19, Volume: 213, Issue:10

Topics: Adipocytes; Animals; Biomarkers, Tumor; Cell Dedifferentiation; Cell Differentiation; Cell Lineage; Cell Proliferation; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Diamines; Dibenzazepines; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ligands; Lipid Metabolism; Liposarcoma; Metabolic Syndrome; Mice, Inbred C57BL; PPAR gamma; Precancerous Conditions; PTEN Phosphohydrolase; Receptors, Notch; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Xenograft Model Antitumor Assays

2016

Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma.

The Journal of biological chemistry, 2003, Apr-04, Volume: 278, Issue:14

Topics: Adipocytes; Dimerization; Enhancer Elements, Genetic; Fibrinolytic Agents; Gene Expression; Humans; Ligands; Liposarcoma; Luciferases; Mutagenesis; Promoter Regions, Genetic; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured

2003